AN2 Therapeutics Balance Sheet (2021-2026) | ANTX

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
12.10M82.52M40.60M28.80M27.22M26.71M40.80M32.62M15.60M24.69M26.77M33.50M21.35M20.00M18.22M18.00M19.90M53.50M
Receivables - Net (Quarter)
0.40M0.60M0.10M
Receivables - Other (Quarter)
0.20M0.20M0.20M0.50M0.40M0.40M0.30M0.30M0.30M0.30M0.40M0.40M0.40M0.30M
Receivables (Quarter)
0.90M1.00M0.50M0.30M0.30M
Prepaid Assets (Quarter)
1.55M1.40M3.48M2.84M2.51M1.77M2.94M2.59M3.21M2.10M2.90M4.26M2.64M2.50M4.61M2.10M1.94M2.20M
Current Assets (Quarter)
60.11M119.78M116.88M107.30M98.62M90.32M98.21M126.41M110.51M116.31M107.44M97.69M86.26M69.56M67.52M64.02M59.94M87.49M
Non-Current Assets
Long-Term Investments (Quarter)
3.49M2.42M1.99M3.22M26.36M27.19M3.90M5.02M11.48M8.30M3.22M2.01M
Other Non-Current Assets (Quarter)
0.72M0.72M0.72M0.72M0.72M0.72M1.04M1.04M1.04M1.04M0.80M0.30M
Non-Current Assets (Quarter)
5.21M0.72M3.14M2.71M3.94M0.77M0.72M27.40M28.24M4.95M1.04M5.83M11.78M8.30M3.22M2.01M
Assets (Quarter)
65.32M120.50M120.02M110.01M102.56M91.08M98.93M153.81M138.74M121.26M108.48M97.69M92.09M81.34M75.83M67.23M61.95M87.49M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.06M2.61M1.61M1.44M2.12M3.54M3.13M4.88M2.68M2.43M1.89M1.71M3.32M3.07M2.11M2.23M3.02M2.62M
Payables (Quarter)
1.06M2.61M1.61M1.44M2.12M3.54M3.13M4.88M2.68M2.43M1.89M1.71M3.32M3.07M2.11M2.23M3.02M2.62M
Accumulated Expenses (Quarter)
0.31M1.15M0.01M1.11M2.17M0.74M6.44M2.20M6.68M0.99M1.84M4.92M1.68M0.53M1.20M1.74M2.42M0.61M
Other Accumulated Expenses (Quarter)
0.04M0.03M0.01M0.12M0.04M0.97M0.10M0.09M0.56M1.27M0.79M0.06M0.72M0.03M0.05M0.57M
Current Leases (Quarter)
0.03M0.01M0.07M0.05M0.03M0.01M
Total Current Liabilities (Quarter)
3.40M5.09M4.15M4.43M7.19M8.57M11.16M14.84M14.04M10.02M10.24M8.72M5.56M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter)
105.47M107.39M109.32M
Other Non-Current Liabilities (Quarter)
0.17M0.17M
Total Non-Current Liabilities (Quarter)
10.24M8.72M5.56M
Total Liabilities (Quarter)
29.84M38.35M3.41M5.09M4.15M4.43M7.19M8.57M11.16M14.84M14.04M10.66M10.13M10.02M10.24M8.01M6.98M6.86M8.89M5.73M
Shareholder's Equity
Common Equity (Quarter)
-29.84M-38.35M-47.41M115.41M115.86M105.57M95.37M82.52M87.76M138.97M124.70M110.60M98.35M87.67M81.85M73.33M68.84M60.38M53.06M81.76M
Shareholder's Equity (Quarter)
-29.84M-38.35M-47.41M115.41M115.86M105.57M95.37M82.52M87.76M138.97M124.70M110.60M98.35M87.67M81.85M73.33M68.84M60.38M53.06M81.76M
Liabilities and Shareholders Equity (Quarter)
65.32M120.50M120.02M110.01M102.56M91.08M98.93M153.81M138.74M121.26M108.48M97.69M92.09M81.34M75.83M67.23M61.95M87.49M
Retained Earnings (Quarter)
-47.38M-56.42M-0.36M-77.88M-0.37M-105.05M-120.85M-137.56M0.28M-171.07M-0.03M-198.25M0.03M-216.43M0.03M-232.24M-241.00M-0.01M
Treasury Shares (Quarter)
0.46M0.62M0.47M0.52M0.87M0.86M1.28M
Shares Outstanding (Quarter)
2.73M2.73M2.73M18.71M19.40M19.40M19.40M19.43M21.93M29.74M29.74M29.82M29.83M29.87M29.92M30.14M27.38M27.37M27.41M35.99M